Vietnam · Delayed Price · Currency is VND HNX:MED Statistics
Total Valuation
HNX:MED has a market cap or net worth of VND 312.73 billion. The enterprise value is 333.60 billion.
| Market Cap | 312.73B |
| Enterprise Value | 333.60B |
Important Dates
The next estimated earnings date is Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
HNX:MED has 12.41 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | 12.41M |
| Shares Outstanding | 12.41M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 37.15% |
| Owned by Institutions (%) | n/a |
| Float | 7.80M |
Valuation Ratios
The trailing PE ratio is 25.83.
| PE Ratio | 25.83 |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | 4.51 |
| P/OCF Ratio | 7.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.79, with an EV/FCF ratio of 4.81.
| EV / Earnings | 27.57 |
| EV / Sales | 0.94 |
| EV / EBITDA | 14.79 |
| EV / EBIT | 19.07 |
| EV / FCF | 4.81 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.54 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 0.72 |
| Interest Coverage | 18.87 |
Financial Efficiency
Return on equity (ROE) is 3.71% and return on invested capital (ROIC) is 2.83%.
| Return on Equity (ROE) | 3.71% |
| Return on Assets (ROA) | 2.27% |
| Return on Invested Capital (ROIC) | 2.83% |
| Return on Capital Employed (ROCE) | 5.39% |
| Revenue Per Employee | 1.08B |
| Profits Per Employee | 36.89M |
| Employee Count | 328 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 3.32 |
Taxes
In the past 12 months, HNX:MED has paid 3.40 billion in taxes.
| Income Tax | 3.40B |
| Effective Tax Rate | 21.93% |
Stock Price Statistics
The stock price has increased by +5.00% in the last 52 weeks. The beta is 0.14, so HNX:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +5.00% |
| 50-Day Moving Average | 25,072.00 |
| 200-Day Moving Average | 24,387.50 |
| Relative Strength Index (RSI) | 54.84 |
| Average Volume (20 Days) | 24,678 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:MED had revenue of VND 355.39 billion and earned 12.10 billion in profits. Earnings per share was 975.46.
| Revenue | 355.39B |
| Gross Profit | 80.73B |
| Operating Income | 17.49B |
| Pretax Income | 15.50B |
| Net Income | 12.10B |
| EBITDA | 22.55B |
| EBIT | 17.49B |
| Earnings Per Share (EPS) | 975.46 |
Balance Sheet
The company has 29.00 billion in cash and 49.87 billion in debt, giving a net cash position of -20.86 billion or -1,681.26 per share.
| Cash & Cash Equivalents | 29.00B |
| Total Debt | 49.87B |
| Net Cash | -20.86B |
| Net Cash Per Share | -1,681.26 |
| Equity (Book Value) | 324.61B |
| Book Value Per Share | 26,157.17 |
| Working Capital | 71.13B |
Cash Flow
In the last 12 months, operating cash flow was 43.89 billion and capital expenditures 25.51 billion, giving a free cash flow of 69.40 billion.
| Operating Cash Flow | 43.89B |
| Capital Expenditures | 25.51B |
| Free Cash Flow | 69.40B |
| FCF Per Share | 5,592.32 |
Margins
Gross margin is 22.72%, with operating and profit margins of 4.92% and 3.40%.
| Gross Margin | 22.72% |
| Operating Margin | 4.92% |
| Pretax Margin | 4.36% |
| Profit Margin | 3.40% |
| EBITDA Margin | 6.34% |
| EBIT Margin | 4.92% |
| FCF Margin | 19.53% |
Dividends & Yields
This stock pays an annual dividend of 900.00, which amounts to a dividend yield of 3.57%.
| Dividend Per Share | 900.00 |
| Dividend Yield | 3.57% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 119.73% |
| Buyback Yield | 0.03% |
| Shareholder Yield | 3.60% |
| Earnings Yield | 3.87% |
| FCF Yield | 22.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:MED has an Altman Z-Score of 2.74 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 6 |